Market Overview:
The global cedar pollen allergy drug market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of cedar pollen allergies, rising awareness about available treatments, and growing demand for effective and safe medications. Cedar pollen allergy drugs are classified into four types: RGI-1001, STG-120, TO-206, and others. The RGI-1001 segment is expected to account for the largest share of the global cedar pollen allergy drug market in 2018. This segment is projected to grow at a CAGR of XX% during the forecast period.
Product Definition:
Cedar pollen allergy drug is used to treat the symptoms of cedar pollen allergy. The importance of this drug is that it can help relieve symptoms such as sneezing, congestion, and itchy eyes.
RGI-1001:
Rising prevalence of food allergies among children and the introduction of novel drugs with different mechanisms of action are expected to drive the market. According to a study published in Food and Allergy Research, around 8% - 10% prevalence rate for food allergy was observed in Europe.
STG-120:
STG-120 is a subcutaneous immunotherapy drug that prevents the release of histamine and other allergic symptoms caused by food antigens in patients with cedar pollen allergy. It was approved by the U.S. FDA for treatment of cedar pollen allergy in December 2017, after it received breakthrough therapy approval for the indication two years earlier.
Application Insights:
In-patient treatment accounted for the largest share of over 70.0% in 2017 owing to the rising prevalence of cedar pollen allergy and growing awareness about its symptoms among patients. In addition, a significant increase in healthcare expenditure along with a high patient count ratio has led to an increased demand for drugs under this category.
Out-patient treatment is expected to witness the fastest growth at a CAGR of XX% from 2018 to 2030 due largely to an increase in product usage as well as awareness regarding allergic rhinitis among patients suffering from cedar pollen allergy or intolerance. Increasing out-patient visits for nasal congestion and rhinitis are also likely drive segment growth over the forecast period (Global Cedar Pollen Allergy Drug Market, by application, 2018).
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of pollen-allergic patients, rising awareness about cedar allergy treatments, and availability of developed healthcare infrastructure are some factors attributing to its largest share. In addition, increasing demand for natural products with novel properties is expected to fuel regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to an increase in disposable income and growing medical tourism industry especially in India and China. Furthermore, rising prevalence of allergic disorders due to changing climatic conditions will drive demand for Cedar Pollen Allergy Drug (CPAD) treatment across this region over the next eight years.
Growth Factors:
- Increasing prevalence of cedar pollen allergy
- Growing awareness about the benefits of cedar pollen allergy drug therapy
- Rising demand for effective and safe cedar pollen allergy drugs
- Technological advancements in cedar pollen allergy drug development and manufacturing process
- Growing number of research studies on the efficacy and safety of cedar pollen allergy drugs
Scope Of The Report
Report Attributes
Report Details
Report Title
Cedar Pollen Allergy Drug Market Research Report
By Type
RGI-1001, STG-120, TO-206, Others
By Application
Out-Patient, In-Patient
By Companies
ALK-Abello A/S, Anergis SA, Circassia Pharmaceuticals Plc, Immunomic Therapeutics, Inc., Japan Tobacco Inc., REGiMMUNE Corporation, ALK-Abello A/S
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
203
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Cedar Pollen Allergy Drug Market Report Segments:
The global Cedar Pollen Allergy Drug market is segmented on the basis of:
Types
RGI-1001, STG-120, TO-206, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Out-Patient, In-Patient
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ALK-Abello A/S
- Anergis SA
- Circassia Pharmaceuticals Plc
- Immunomic Therapeutics, Inc.
- Japan Tobacco Inc.
- REGiMMUNE Corporation
- ALK-Abello A/S
Highlights of The Cedar Pollen Allergy Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- RGI-1001
- STG-120
- TO-206
- Others
- By Application:
- Out-Patient
- In-Patient
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cedar Pollen Allergy Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cedar pollen allergy drug is a medication used to treat people who have an allergic reaction to cedar pollen. It works by blocking the body's response to cedar pollen.
Some of the key players operating in the cedar pollen allergy drug market are ALK-Abello A/S, Anergis SA, Circassia Pharmaceuticals Plc, Immunomic Therapeutics, Inc., Japan Tobacco Inc., REGiMMUNE Corporation, ALK-Abello A/S.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cedar Pollen Allergy Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cedar Pollen Allergy Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cedar Pollen Allergy Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cedar Pollen Allergy Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cedar Pollen Allergy Drug Market Size & Forecast, 2020-2028
4.5.1 Cedar Pollen Allergy Drug Market Size and Y-o-Y Growth
4.5.2 Cedar Pollen Allergy Drug Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 RGI-1001
5.2.2 STG-120
5.2.3 TO-206
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Out-Patient
6.2.2 In-Patient
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cedar Pollen Allergy Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cedar Pollen Allergy Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 RGI-1001
9.6.2 STG-120
9.6.3 TO-206
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Out-Patient
9.10.2 In-Patient
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 RGI-1001
10.6.2 STG-120
10.6.3 TO-206
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Out-Patient
10.10.2 In-Patient
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 RGI-1001
11.6.2 STG-120
11.6.3 TO-206
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Out-Patient
11.10.2 In-Patient
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 RGI-1001
12.6.2 STG-120
12.6.3 TO-206
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Out-Patient
12.10.2 In-Patient
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 RGI-1001
13.6.2 STG-120
13.6.3 TO-206
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Out-Patient
13.10.2 In-Patient
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cedar Pollen Allergy Drug Market: Competitive Dashboard
14.2 Global Cedar Pollen Allergy Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ALK-Abello A/S
14.3.2 Anergis SA
14.3.3 Circassia Pharmaceuticals Plc
14.3.4 Immunomic Therapeutics, Inc.
14.3.5 Japan Tobacco Inc.
14.3.6 REGiMMUNE Corporation
14.3.7 ALK-Abello A/S
